DrugAlert provides timely advice direct to your inbox and is based on information from drug manufacturers regarding critical changes to medication access such as the discontinuation, short supply or unavailability, recalls and other important drug-related information. See below to view the most recent volumes of DrugAlert.
HPS Pharmacies wish to give notice that Seqirus, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Palexia® SR as follows: Palexia® SR 50mg Tablets Tapentadol (as hydrochloride) 50…
Read more
HPS Pharmacies wish to give notice that Medsurge, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for folic acid injectables as follows: Folic Acid Ampoules Folic acid 5mg/1mL Products…
Read more
HPS Pharmacies wishes to advise that Aspen Pharmacare is discontinuing Xylocaine 0.5% With Adrenaline 1:200,000 injection vials as follows: Xylocaine 0.5% With Adrenaline 1:200,000 Vial 20mL Adrenaline (epinephrine) acid tartrate + Lidocaine hydrochloride ARTG…
Read more
Further to DrugAlert vol 957, HPS Pharmacies wish to advise that multiple suppliers are continuing to experience a supply interruption for various IV fluids, including all volumes of the following products: Glucose 5% bags…
Read more
HPS Pharmacies wish to give notice that Viatris is updating the packaging of their metoprolol vials as follows: Metoprolol IV Viatris Vials Metoprolol tartrate 5mg/5mL ARTG 204665 The new packaging for this product will…
Read more
HPS Pharmacies wish to advise that multiple suppliers are experiencing supply interruptions for various IV fluids, including all volumes of the following products: Glucose 5% bags (Baxter, B. Braun, Frensenius Kabi) Hartmann’s solution bags…
Read moreDrug Recall for Palexia® SR 50mg (Aug. 21 2024)
Drug Recall for Folic Acid Injectables (Aug. 16 2024)
Discontinuation of Xylocaine 0.5% With Adrenaline 1:200,000 (Aug. 14 2024)
Availability of IV Fluids Update (Aug. 12 2024)
Packaging Update for Metoprolol IV Viatris 5mg/5mL (Aug. 07 2024)
Availability of Intravenous Fluids (Jul. 24 2024)
Discontinuation of Symbicort® Rapihaler™ 50/3 (Jul. 17 2024)
Availability of Ozempic® (Jul. 17 2024)
Discontinuation of Timoptol® and Timoptol®-XE Eye Drops (Jul. 17 2024)
Safety Notice – Adrenaline Aguettant 1:10,000 (1 mg / 10 mL) PFS (Jul. 17 2024)
Discontinuation of Depo-Provera® and Depo-Ralovera® Vials (Jul. 15 2024)
Availability of Gentamicin Ampoules (Jul. 11 2024)
Medicine Safety Alert for Andrographis – Anaphylaxis Risk (Jul. 10 2024)
Drug Recall for Aciclovir ACCORD 500 mg/ 20mL injection vials (Jul. 05 2024)
Availability of Morphine Oral Solution (Jun. 28 2024)
Availability of OxyNorm® (Jun. 28 2024)
Availability of Wafermine™ Update (Jun. 27 2024)
Availability of Wafermine™ (Jun. 17 2024)
Availability of Clexane® 40mg (Jun. 13 2024)
Defect Correction for Sublimaze® Injection (Jun. 07 2024)
Availability of Gentamicin Ampoules (Jun. 05 2024)
Recall for Levomepromazin-Neuraxpharm Ampoules (May. 31 2024)
Availability of Cisplatin (May. 30 2024)
Availability of Epirubicin (May. 30 2024)
Packaging Update for Medsurge Hydromorphone 2 mg/1 mL (May. 29 2024)
Availability of Solu-Cortef® Act-O-Vial (May. 27 2024)
Availability of Clexane® 60mg (May. 20 2024)
Discontinuation of Oruvail® SR and Orudis® SR (May. 10 2024)
Availability of Orencia® (May. 09 2024)
Availability of Octreotide Ampoules (May. 03 2024)
Defect Correction and Recall Update for Panadol® Children 100mg/mL (May. 01 2024)
Defect Correction for Ryaltris® Nasal Spray (Apr. 30 2024)
Defect Correction for Panadol® Children 100mg/mL (Apr. 29 2024)
Availability of Orencia® (Apr. 29 2024)
Discontinuation of Lasix® 40mg Ampoules (Apr. 23 2024)
Discontinuation of Tracleer® Tablets (Apr. 23 2024)
Discontinuation of Voltaren® Eye Drops and Suppositories (Apr. 17 2024)
Drug Recall for K-Citra 10 Tablets (Apr. 09 2024)
Availability of Local Anaesthetic Products (Apr. 04 2024)
Availability of Fresofol® 1% MCT/LCT (Apr. 04 2024)
PBS Subsidies for Morphine Oral Solution (Apr. 03 2024)
Availability of Trimethoprim (Mar. 27 2024)
Availability of Heparin 5,000IU/5mL (Mar. 26 2024)
Discontinuation of Metalyse® 40mg (Mar. 25 2024)
Availability of Gliclazide (Feb. 29 2024)
Availability of Morphine Oral Solution (Feb. 29 2024)
Defect Correction for ADT™ Booster (Feb. 21 2024)
Availability of Local Anaesthetic Products (Feb. 15 2024)
Availability of DBL™ Magnesium Sulfate (Feb. 15 2024)
Discontinuation of Vivaxim® Injection (Feb. 14 2024)
Availability of Parenteral Paracetamol (Feb. 13 2024)
Discontinuation of DBL™ Hyoscine Hydrobromide Ampoules (Feb. 01 2024)
Availability of Bicillin® L-A (Feb. 01 2024)
Defect Correction for Spiriva® Respimat® (Jan. 31 2024)
COVID therapies and the National Medication Stockpile (Victoria) (Jan. 31 2024)
Availability of BCG Bladder Instillation (Jan. 31 2024)
Insulin Cartridge Defect Alert (Jan. 22 2024)
Drug Recall for Metformin Sandoz 1000mg (Jan. 22 2024)
Service Update for ClopineCENTRAL® (Jan. 17 2024)
Discontinuation of Imigran® Nasal Spray and Injection® (Jan. 12 2024)
Availability of Xylocaine with Adrenaline (Dec. 21 2023)
Update on InterPharma Sodium Chloride 0.9% ampoules (Dec. 15 2023)
Drug Recall for InterPharma Sodium Chloride 0.9% 30mL (Dec. 01 2023)
Drug Quarantine Update for InterPharma Sodium Chloride 0.9% (Nov. 28 2023)
Drug Quarantine for InterPharma Sodium Chloride 0.9% (Nov. 24 2023)
Drug Recall for Lisinopril Sandoz (Nov. 13 2023)
Discontinuation of OxyNorm®, MS Mono® and Sevredol® (Nov. 01 2023)
Drug Recall for Dasatinib Dr.Reddy’s (Oct. 27 2023)
Packaging Update for Baxter Compounded IV Bags (Oct. 23 2023)
Packaging Update for Potassium Chloride 22.3% Concentrated Injection (Oct. 17 2023)
Recall of Sodium Chloride 0.9% Freeflex 100mL injection bag (Oct. 13 2023)
Defect Correction for Midazolam Alphapharm (Sep. 26 2023)
Availability of Morphine Oral Solution (Sep. 01 2023)
Availability of Mirena® (Aug. 01 2023)
Availability of Lidocaine Ampoules (Jul. 27 2023)
Availability of Nizatidine (Jul. 26 2023)
Drug Recall for Sabril® (Jul. 21 2023)
Discontinuation of Ordine® Oral Solution (Jun. 15 2023)
Discontinuation of Ordine® Oral Solution (Jun. 07 2023)
Discontinuation of Capoten® Oral Liquid (Jun. 05 2023)
Availability of Septrin® Oral Liquid (Jun. 05 2023)
Discontinuation of Diazepam Rectal Solution (Jun. 05 2023)
Availability of Vasodrine® Tablets (May. 26 2023)
Availability of Local Anaesthetic Products (May. 25 2023)
Availability of Edronax® (May. 25 2023)
Availability of Dostinex® (May. 25 2023)
Availability of Synarel® (May. 25 2023)
Availability of Heparin 5,000IU/5mL (May. 24 2023)
Availability of Heparinised Saline (May. 24 2023)
Availability of Actilyse® (May. 15 2023)
Availability of Nizatidine (May. 15 2023)
Product Defect Correction – Water for Injection ampoules co-packed with Simulect® (May. 08 2023)
Availability of Pfizer Potassium Chloride Ampoules (May. 04 2023)
Availability of Souvenaid® (May. 02 2023)
Availability of Cefaclor (May. 02 2023)
Availability of Lanoxin® Ampoules (Apr. 28 2023)
Availability of Somac® Granules (Apr. 26 2023)
Availability of Glaumox® Vials (Apr. 26 2023)
Availability of Bromhexine Oral Liquid (Apr. 26 2023)
Availability of Suxamethonium Juno (Apr. 12 2023)
Availability of Local Anaesthetic Products (Apr. 12 2023)
Availability of Synarel® Nasal Spray (Mar. 30 2023)
Availability of Warfarin (Mar. 20 2023)
Removal of Iopidine® Eye Drops from PBS (Mar. 10 2023)
Availability of Coumadin® (Mar. 10 2023)
Availability of Celestone® Chronodose® Injection Ampoule (Mar. 07 2023)
Updated Packaging for Coumadin® and Marevan® (Mar. 01 2023)
Availability of Fentanyl Intranasal (Mar. 01 2023)
Availability of Local Anaesthetic Products (Mar. 01 2023)
Recall of Pholcodine-Containing Products (Mar. 01 2023)
Discontinuation of Phebra Folic Acid Vials (Feb. 23 2023)
Availability of Diazepam Rectal Solution (Feb. 21 2023)
Availability of Teicoplanin (Feb. 17 2023)
Availability of Celestone® Chronodose® Injection Ampoule (Feb. 17 2023)
Availability of Cefuroxime (Feb. 17 2023)
Recall of Celestone® Chronodose® Injection Ampoule (Feb. 15 2023)
Discontinuation of Riodine® S Surgical Scrub (Feb. 13 2023)
Availability of Temgesic® Sublingual Tablets (Feb. 09 2023)
Discontinuation of Cabazitaxel 60mg/1.5mL (Feb. 07 2023)
Availability of Fluconazole-Baxter Vials (Feb. 02 2023)
Availability of Difflam® Solution (Feb. 01 2023)
Removal of Androderm® from PBS (Jan. 31 2023)
Discontinuation of Byetta® (Jan. 31 2023)
Product Defect Alert for Vancomycin Viatris Vials (Jan. 24 2023)
Availability of Fentanyl Intranasal (Jan. 20 2023)
Product Defect Alert – Veletri® Consumables Kit (Jan. 13 2023)
Availability of Antibiotics (Jan. 11 2023)
Recall of Pharmacy Action Dry Cough Relief (Dec. 29 2022)
Recall of Medsurge Mupirocin Nasal Ointment (Dec. 29 2022)
Defect Alert for CADD™ Infusion System Disposables (Dec. 23 2022)
Availability of Imdur® and Monodur® (Dec. 23 2022)
Availability of Cefalexin Suspension (Dec. 23 2022)
Availability of Mestinon® (Dec. 19 2022)
Recall of Quinapril (Dec. 19 2022)
Availability of Trimethoprim (Dec. 14 2022)
Availability of Trulicity® (Dec. 01 2022)
Availability of Ozempic® (Dec. 01 2022)
Availability of Amoxicillin + Clavulanic Acid (Nov. 25 2022)
Discontinuation of Chirocaine® (Nov. 22 2022)
Removal of Rebif® from PBS (Nov. 17 2022)
Discontinuation of Otrivin® Nasal Drops (Nov. 17 2022)
Availability of Phenobarbital Elixir (Nov. 14 2022)
Discontinuation of Jurnista® (Nov. 14 2022)
Availability of Riodine® (Nov. 11 2022)
Availability of Amoxicillin (Nov. 09 2022)
Drug Recall for DBL™ Vancomycin 500mg Vials (Nov. 09 2022)
Defect Correction for Minisart® Filters (Nov. 03 2022)
Removal of temporary tocilizumab PBS listings (Nov. 03 2022)
Discontinuation of Chlorhexidine 0.2% Catheter Prep Ampoule (Oct. 25 2022)
Availability of Metalyse® (Oct. 13 2022)
Availability of Metronidazole (Oct. 12 2022)
Availability of Ilevro® Eye Drops (Oct. 12 2022)
Availability of Vancomycin Vials (Oct. 06 2022)
Availability of Amoxicillin + Clavulanic Acid 875/125mg (Sep. 14 2022)
Availability of Amoxicillin 250mg/5mL (Sep. 14 2022)
Product Alert for Trikafta® (Sep. 06 2022)
Availability of Atracurium (Aug. 31 2022)
Availability of Metronidazole Tablets (Aug. 30 2022)
Availability of Amoxicillin + Clavulanic Acid 875/125mg (Aug. 23 2022)
Availability of Trulicity® (Aug. 11 2022)
Availability of Ozempic® (Aug. 11 2022)
Availability of Pulmicort® Turbuhaler® (Aug. 03 2022)
Packaging alert for Xylocaine® 2% with Adrenaline (Aug. 02 2022)
Availability of Cetrotide® (Jul. 29 2022)
Availability of Vecure® (Jul. 27 2022)
Availability of Morphine Juno 50mg Ampoules (Jul. 26 2022)
Availability of BenPen™ (Jul. 19 2022)
Availability of Chlorsig® Ointment (Jul. 19 2022)
Availability Of Metronidazole Tablets (Jul. 18 2022)
Availability Of Ropivacaine Kabi 0.2% (Jul. 08 2022)
Availability of Metaraminol GH Pharma 3mg/6mL (Jul. 08 2022)
Availability of Metalyse® (Jun. 27 2022)
Labelling Change for Calcium Gluconate Injection (Jun. 24 2022)
Availability of Mivacron® (Jun. 17 2022)
Availability of Targin® (Jun. 16 2022)
Availability of Fresofol® 1% MCT/LCT (Jun. 16 2022)
Availability of Atracurium (Jun. 10 2022)
Availability of Modified-Release Oxycodone (Jun. 10 2022)
Availability of Ozempic® (Jun. 02 2022)
Availability of Targin® (May. 20 2022)
Availability of ‘Marcain 0.5% with Adrenaline’ (May. 18 2022)
Defect Alert for Fentanyl GH 100mcg/2mL (May. 11 2022)
Availability of Elastomeric Device LV-10 (May. 06 2022)
Availability of Xylocaine 0.5% with Adrenaline (May. 03 2022)
Availability of ‘Xylocaine with Adrenaline’ and ‘Marcain with Adrenaline’ (May. 03 2022)
Drug Recall for DBL™ Vancomycin (Apr. 27 2022)
Availability of Targin® (Apr. 14 2022)
Availability of Oxycodone Modified-Release Tablets (Apr. 12 2022)
Packaging change for Sodium Chloride 0.9% Injection (Apr. 11 2022)
Availability of Povidone-Iodine Solution Ampoules (Apr. 07 2022)
Availability of Dexamethasone 4mg/1mL Vials (Apr. 07 2022)
Availability of Miochol-E® (Apr. 05 2022)
Discontinuation of Calmoseptine® Ointment (Mar. 23 2022)
Availability of Urokinase (Mar. 21 2022)
Availability of Targin® (Mar. 18 2022)
Product Notice for Zavicefta® Injection (Mar. 18 2022)
Availability of Ephedrine Sulfate (Mar. 04 2022)
Availability of Clopine® Suspension (Mar. 04 2022)
Labelling Change for Sodium Bicarbonate 8.4% Injection (Mar. 01 2022)
Labelling Change for Magnesium Sulfate Heptahydrate 50% (Feb. 25 2022)
Availability of Orencia® Syringes and Autoinjector (Feb. 11 2022)
Availability of OncoTICE® (Feb. 02 2022)
Availability of Dilaudid® Tablets (Feb. 01 2022)
Availability of Temgesic® (Jan. 24 2022)
Availability of Fleet® (Jan. 21 2022)
Discontinuation of Lucrin® 5mg/mL Vials (Jan. 21 2022)
Availability of Solprin® (Jan. 14 2022)
Availability of Prasugrel (Jan. 14 2022)
Discontinuation of CoPlavix® (Jan. 12 2022)
Labelling Change for Calcium Gluconate Injection (Jan. 11 2022)
Labelling Change for Calcium Gluconate Injection (Dec. 21 2021)
Availability of Local Anaesthetic Products (Dec. 03 2021)
Discontinuation of Rulide® D (Dec. 03 2021)
Availability of Elastomeric Devices (Nov. 29 2021)
Availability of Local Anaesthetic Products (Nov. 29 2021)
Formulation Change for Ibrance® (Nov. 29 2021)
Discontinuation of Citracal® (Nov. 09 2021)
Product Defect Alert for Novo Nordisk Insulins (Nov. 09 2021)
Availability of Caldolor® (Oct. 28 2021)
Availability of Heparin (Oct. 27 2021)
Availability of Emend® IV (Oct. 19 2021)
Availability of Span-K® (Oct. 15 2021)
Availability of Acetylcysteine Ampoules (Oct. 08 2021)
Availability of Cisatracurium (Oct. 01 2021)
Availability of Imdur® and Monodur® (Sep. 23 2021)
Discontinuation of Propofol Sandoz® (Sep. 21 2021)
Availability of Daivobet® (Sep. 21 2021)
Packaging Update for Revlimid® and Pomalyst® (Sep. 21 2021)
Availability of Local Anaesthetic Products (Sep. 16 2021)
Availability of Targin® (Sep. 10 2021)
Availability of Local Anaesthetic Products (Sep. 06 2021)
Labelling Change for Potassium Chloride Ampoules (Sep. 06 2021)
Availability of Olimel® N9-840E (Sep. 03 2021)
Stability of Actemra® Vials (Sep. 02 2021)
Discontinuation of Lovan® (Aug. 23 2021)
Availability of Progynova® (Aug. 16 2021)
Product Safety Information for Dilantin® (Aug. 11 2021)
Drug Recall for Avsartan® (Aug. 11 2021)
Drug Recall for Champix® (Aug. 02 2021)
Availability of Actemra® (Jul. 28 2021)
Administration Advice for KabiPac® (Jul. 22 2021)
Availability of Nifedipine (Jul. 21 2021)
Discontinuation of Intal® Forte (Jul. 20 2021)
Appearance Issue for Tofranil® (Jul. 16 2021)
Discontinuation of Ciprofloxacin Alphapharm (Jul. 15 2021)
Discontinuation of Pregnyl® (Jul. 14 2021)
Availability of Folic Acid Vials (Jul. 13 2021)
Availability of Carbosorb® X (Jul. 12 2021)
Availability of Local Anaesthetic Products (Jul. 12 2021)
Availability of Actemra® (Jul. 12 2021)
Product Defect Alert for Recothrom® (Jun. 22 2021)
Availability of Sodium Citrate (Jun. 15 2021)
Availability of Diazepam Rectal Solution (Jun. 15 2021)
Availability of Tranexamic Acid Tablets (Jun. 15 2021)
PBS Change for Fragmin® (Jun. 09 2021)
Discontinuation of Aciclovir Intravenous Infusion (Pfizer) (Jun. 08 2021)
Product Defect Alert for Ospolot® (Jun. 07 2021)
Availability of Diazepam Rectal Solution (Jun. 03 2021)
Presentation Change for Phenasen® (Jun. 01 2021)
Availability of Nitrofurantoin (May. 30 2021)
Availability of Cernevit® (May. 26 2021)
Recall of Hydralyte® Strawberry Kiwi Effervescent Electrolyte Tablets (May. 25 2021)
Discontinuation of Kaluril® (May. 25 2021)
Availability of Miochol-E® (May. 21 2021)
Availability of Carbosorb® XS (May. 21 2021)
Packaging Change for AmBisome® (May. 20 2021)
Availability of Progynova® (May. 13 2021)
Availability of Cocaine Products (May. 13 2021)
Availability of Panadol® Suppositories (May. 10 2021)
Discontinuation of Edecrin® (May. 07 2021)
Removal of Baraclude® from the PBS (May. 05 2021)
Presentation Change of Ropivacaine Kabi (May. 04 2021)
Availability of Mucosoothe® Oral Gel (May. 04 2021)
Availability of Local Anaesthetic Products (Apr. 30 2021)
Availability of Clexane® (Apr. 29 2021)
Availability of Cocaine Products (Apr. 23 2021)
Presentation Change for Morphine Juno (Apr. 16 2021)
Availability of Aciclovir Eye Ointment (Apr. 15 2021)
Availability of Phenelzine (Apr. 09 2021)
Availability of Local Anaesthetic Products (Apr. 08 2021)
Presentation of Salbutamol Inhalers (Apr. 06 2021)
Availability of Synacthen® (Apr. 01 2021)
Availability of Ketorolac Ampoules (Apr. 01 2021)
Availability of Fresofol® (Mar. 31 2021)
Recall of Histoacryl® (Mar. 30 2021)
Discontinuation of DBL™ Cephalothin (Mar. 30 2021)
Discontinuation of Urocit®-K (Mar. 26 2021)
Availability of Stemetil® Ampoules (Mar. 26 2021)
Discontinuation of Ranitidine (Mar. 15 2021)
Availability of Nitrostat® (Mar. 10 2021)
Availability of Diasp® (Mar. 05 2021)
Discontinuation of MS Contin® Suspension (Mar. 04 2021)
Availability of Intralipid® (Mar. 03 2021)
Discontinuation of DBL™ Papaverine (Mar. 03 2021)
Availability of Urex® Forte (Mar. 02 2021)
Availability of Predsol® Suppositories (Feb. 25 2021)
Availability of Prednefrin® Forte (Feb. 25 2021)
Availability of Famciclovir Tablets (Feb. 25 2021)
Availability of Indometacin Capsules (Feb. 23 2021)
Product Defect Correction for AmBisome® (Feb. 15 2021)
Removal of Mabthera® IV and Tarceva® from the PBS (Feb. 12 2021)
Discontinuation of Dilaudid® Oral Liquid (Feb. 04 2021)
Safety Notice for Minisart® NML / Ophthalsart (Jan. 28 2021)
Ergometrine maleate injection (500 microgram/mL) ampoule (Jan. 22 2021)
Product Defect Alert for Methotrexate Accord (Dec. 24 2020)
Recall of Tenofovir Disoproxil Emtricitabine Mylan (Dec. 23 2020)
Availability of Sertraline (Dec. 23 2020)
Availability of Estradot® (Dec. 22 2020)
Discontinuation of Diacol® (Dec. 21 2020)
Availability of Fibro-Vein™ (Dec. 18 2020)
Discontinuation of DBL™ Irinotecan (Dec. 16 2020)
Availability of Glyceryl Trinitrate (Dec. 03 2020)
Availability of Qvar® (Nov. 13 2020)
Availability of Cytotec® (Nov. 05 2020)
Availability of Teveten® (Nov. 02 2020)
Availability of Eliquis® (Nov. 02 2020)
Product Notice for Milrinone (Nov. 02 2020)
Availability of Tranylcypromine (Oct. 20 2020)
Availability of DBL™ Leucovorin Calcium (Oct. 15 2020)
Availability of Voltaren® Ophtha (Oct. 14 2020)
Availability of Cilicaine® Syringe (Oct. 13 2020)
Availability of Alphagan® P (Oct. 08 2020)
Availability of Urex® Forte (Sep. 25 2020)
Discontinuation of Glucose Intravenous Infusion BP 5% (Sep. 25 2020)
Availability of Panadol® Suppositories (Sep. 25 2020)
Product Notice for Local Anaesthetics (Sep. 18 2020)
Discontinuation of Tinidazole (Sep. 15 2020)
Recall of Pharmacy Action Antiseptic Cream (Sep. 11 2020)
Product Notice for Sinemet® Tablets (Sep. 10 2020)
Availability of Tambocor® Ampoules (Sep. 01 2020)
Availability of Local Anaesthetic Products (Sep. 01 2020)
Availability of Intranasal Minirin® (Aug. 31 2020)
Availability of Sinemet® CR (Aug. 31 2020)
Availability of DBL™ Magnesium Sulfate Ampoules (Aug. 24 2020)
Availability of Intal® and Intal Forte® (Aug. 24 2020)
Availability of Captopril (Aug. 24 2020)
Availability of Chlorhexidine Pre-Op Wash (Aug. 21 2020)
Availability of Phenytoin Ampoules (Aug. 18 2020)
Availability of Suxamethonium (Aug. 18 2020)
Safety Advisory for Oxycodone Sandoz® (Aug. 14 2020)
Availability of Brevinor® and Norimin® (Aug. 14 2020)
Recall of Abstral® (Aug. 12 2020)
Availability of Clexane® (Aug. 11 2020)
Availability of Healon GV® (Aug. 11 2020)
Discontinuation of Fresofol® LCT (Aug. 03 2020)
Availability of Gastrogel® (Aug. 03 2020)
Availability of Local Anaesthetic Products (Aug. 03 2020)
Availability of Vancomycin Alphapharm (Jul. 27 2020)
Availability of Symbicort® Rapihaler® (Jul. 27 2020)
Availability of Zoely® Tablets (Jul. 22 2020)
Availability of Minirin® Nasal Spray (Jul. 22 2020)
Recall of Sodium Chloride Bags (Jul. 10 2020)
Availability of Local Anaesthetic Products (Jul. 01 2020)
Availability of Suxamethonium (Jul. 01 2020)
Recall of Abstral® (Jul. 01 2020)
Discontinuation of Roferon-A® (Jun. 18 2020)
Defect Correction for Tacrolimus Apotex (Jun. 02 2020)
Availability of Marevan® (May. 22 2020)
Availability of Fresofol® (May. 21 2020)
Discontinuation of Effient® (May. 20 2020)
Availability of Artane® (May. 19 2020)
Availability of Pulmicort® & Symbicort® Turbuhalers® (May. 18 2020)
Availability of Metformin (May. 14 2020)
Discontinuation of Isuprel™ (Apr. 29 2020)
Availability of Local Anaesthetic Products (Apr. 28 2020)
Discontinuation of Asasantin® SR and Persantin® SR (Apr. 22 2020)
Availability of Metronidazole (Apr. 22 2020)
Availability of Cisatracurium (Apr. 20 2020)
Availability of Aminophylline Ampoules (Apr. 17 2020)
Availability of Dobutamine Injection (Apr. 17 2020)
Availability of Levothyroxine (Apr. 09 2020)
Availability of Suxamethonium Ampoules (Apr. 09 2020)
Availability of Ipratropium Nebules (Apr. 07 2020)
Availability of Aminophylline Ampoules (Apr. 07 2020)
Discontinuation of Nardil® (Apr. 06 2020)
Availability of Gentamicin (Apr. 02 2020)
Availability of Local Anaesthetic Products (Apr. 01 2020)
Availability of Adrenaline (Epinephrine) (Mar. 25 2020)
Defect correction for Palexia® SR 100mg (Mar. 24 2020)
Availability of Quinapril (Mar. 18 2020)
Availability of Firmagon® (Mar. 16 2020)
Availability of Lubricating Eye Ointments (Mar. 06 2020)
Availability of Antabuse® (Mar. 05 2020)
Availability of Nifedipine (Mar. 04 2020)
Availability of Hydrocortisone Tablets (Mar. 03 2020)
Availability of Tilade® (Mar. 03 2020)
Availability of Local Anaesthetic Products (Mar. 02 2020)
Availability of Glucose Intravenous Infusion (Feb. 26 2020)
Availability of Ephedrine Hydrochloride (Feb. 26 2020)
Availability of OsmoLax® (Feb. 26 2020)
Availability of Famotidine (Feb. 26 2020)
Availability of BenPen™ (Feb. 21 2020)
Availability of Carbimazole (Feb. 21 2020)
Availability of Calcium Gluconate Gel (Feb. 21 2020)
Availability of Pindolol (Feb. 21 2020)
Availability of Bleomycin Vials (Feb. 21 2020)
Availability of Prazosin (Feb. 20 2020)
Availability of Phenoxymethylpenicillin (Feb. 20 2020)
Availability of Dantrolene (Feb. 20 2020)
Availability of Minipress® (Feb. 20 2020)
Availability of Verapamil Tablets (Feb. 19 2020)
Availability of Carafate® Tablets (Feb. 19 2020)
Availability of Pneumovax® 23 (Feb. 18 2020)
Availability of Span-K® Tablets (Feb. 17 2020)
Availability of Irinotecan (Feb. 17 2020)
Defect correction for Palexia® SR 100mg (Feb. 14 2020)
Availability of Haemorol™ (Feb. 14 2020)
Availability of Primacin® (Feb. 14 2020)
Availability of EpiPen® Jr. (Feb. 14 2020)
Availability of Amoxicillin & Clavulanic Acid Suspension (Feb. 12 2020)
Availability of Emollient Ointment Sterile (Feb. 11 2020)
Availability of Hydroxocobalamin Ampoules (Feb. 11 2020)
Availability of Fleet® Ready-to-Use Enema (Feb. 07 2020)
Availability of Gentamicin Ampoules (Feb. 07 2020)
Availability of Hand Sanitisers (Feb. 07 2020)
Availability of Ciprofloxacin IV (Feb. 07 2020)
Availability of Zyban® SR Tablets (Feb. 06 2020)
Availability of DBL™ Rocuronium Bromide Vials (Feb. 05 2020)
Availability of Gastrogel Antacid® Oral Suspension (Feb. 05 2020)
Availability of Integrilin® (Feb. 05 2020)
Availability of Tamoxifen Tablets (Feb. 04 2020)
Availability of Ferro-Grad C® Tablets (Feb. 04 2020)
Availability of Minims® Phenylephrine Eye Drops (Feb. 04 2020)
Availability of Panadol® Suppositories (Feb. 04 2020)
Discontinuation of Zantac® Effervescent (Feb. 03 2020)
Availability of Nitrostat® Tablets (Jan. 31 2020)
Availability of Isoprenaline Ampoules (Jan. 30 2020)
Appearance Change for Temazepam Tablets (Jan. 30 2020)
Availability of Pethidine (Jan. 24 2020)
Availability of Minims® Phenylephrine Eye Drops (Jan. 23 2020)
Availability of Sodium Bicarbonate Vials (Dec. 20 2019)
Availability of Local Anaesthetic Products (Dec. 20 2019)
Availability of Hyalase® (Dec. 20 2019)
Availability of Phenelzine (Dec. 20 2019)
Availability of Famotidine (Dec. 19 2019)
Notice For EpiPen® Jr. (Dec. 17 2019)
Availability of Kenacort®-A 40 (Dec. 10 2019)
Availability Of Heparin (Dec. 04 2019)
Availability of Local Anaesthetic Products (Dec. 02 2019)
Availability of Marcain with Fentanyl (Nov. 22 2019)
Availability Of Nizatidine Capsules (Nov. 15 2019)
Availability of Nizatidine Capsules (Nov. 14 2019)
Availability of Cyclizine Ampoules (Oct. 31 2019)
Product Notice for Clexane® Syringes (Oct. 29 2019)
Availability of Cefalotin (Oct. 29 2019)
Availability of Gentamicin (Oct. 28 2019)
Availability of Docetaxel (Oct. 25 2019)
Availability of Tranylcypromine (Oct. 25 2019)
Availability of Cefalotin (Oct. 25 2019)
Availability of Kenacort®-A 40 (Oct. 24 2019)
Availability of OncoTICE® (Oct. 16 2019)
Availability of Tranylcypromine (Oct. 11 2019)
Discontinuation of Morphine Tartrate (Oct. 11 2019)
Availability of Azithromycin Vials (Oct. 07 2019)
Recall of Ranitidine Products (Oct. 07 2019)
Availability of Heparin Sodium (Oct. 03 2019)
Zantac® Products (Oct. 02 2019)
Ranitidine Products (Oct. 02 2019)
Availability of Local Anaesthetic Products (Sep. 23 2019)
Product Notice for Metaraminol Juno Syringes (Sep. 23 2019)
Ranitidine Products (Sep. 23 2019)
Product Notice for Metaraminol Juno Pre-Filled Syringes (Sep. 19 2019)
Safety Alert for Ranitidine (Sep. 18 2019)
Availability of Span-K® Tablets (Sep. 17 2019)
Availability of Midazolam (Sep. 03 2019)
Availability of Adrenaline (Sep. 03 2019)
Availability of Sodium Citrate Dihydrate (Sep. 03 2019)
Availability of Tranylcypromine (Aug. 30 2019)
Availability of Sulfamethoxazole + Trimethoprim Ampoules (Aug. 30 2019)
Availability of Morphine Tartrate (Aug. 27 2019)
Availability of Local Anaesthetic Products (Aug. 26 2019)
Availability of Heparin (Aug. 19 2019)
Discontinuation of Timoptol-XE® 0.25% (Aug. 14 2019)
Quarantine Update for Baxter Infusion Bags (Aug. 06 2019)
Product Notice for Juno Pre-Filled Syringes (Aug. 06 2019)
Discontinuation of Pfizer Antibiotics (Aug. 06 2019)
Availability of BenPen (Aug. 01 2019)
Availability of Nicorandil (Aug. 01 2019)
Availability of Local Anaesthetic Products (Aug. 01 2019)
Product Defect Correction for Endone® (Jul. 31 2019)
Quarantine for Endone® (Jul. 29 2019)
Availability of Ventolin® Syrup (Jul. 24 2019)
Discontinuation of Gelclair® Oral Gel (Jul. 24 2019)
Discontinuation of Calsource® Ca1000 (Jul. 16 2019)
Discontinuation of Saizen® 3mg (Jul. 16 2019)
Availability of Azithromycin (Jul. 16 2019)
Baxter Potassium Chloride Intravenous Infusion Bag (Jul. 15 2019)
Availability of Folinic Acid Vials (Jul. 03 2019)
Discontinuation of Keytruda® 50mg (Jul. 03 2019)
Availability of OncoTICE® (Jul. 03 2019)
Availability of Miochol-E (Jul. 02 2019)
Availability of Pethidine (Jul. 02 2019)
Availability of Heparin (Jun. 19 2019)
Availability of Local Anaesthetic Products (Jun. 19 2019)
Availability of Fentanyl Ampoules (Jun. 17 2019)
Availability of Local Anaesthetic Products (Jun. 13 2019)
Availability of Zyban® SR (Jun. 06 2019)
Availability of Heparin (Jun. 05 2019)
Availability of Local Anaesthetic Products (Jun. 03 2019)
Availability of Septrin® Oral Liquid (May. 31 2019)
Packaging Update for Laceraine® (May. 31 2019)
Safety Alert for Adrenaline (May. 30 2019)
Availability of Ventolin® Ampoules (May. 24 2019)
Recall for Curam Duo (May. 22 2019)
Availability of Pemetrexed (May. 17 2019)
Availability of Irbesartan (May. 16 2019)
Availability of Flucloxacillin (May. 16 2019)
Availability of Metoclopramide Ampoules (May. 14 2019)
Availability of Priorix® and Priorix-Tetra® (May. 09 2019)
Availability of Fentanyl Ampoules (May. 09 2019)
Availability of Minims® Eye Drops (May. 09 2019)
Availability of Fentanyl Ampoules (Apr. 26 2019)
Product Recall for Myxazole® (Apr. 24 2019)
Availability of Bleomycin Vials (Apr. 23 2019)
Availability of Local Anaesthetic Products (Apr. 23 2019)
Availability of Oxycodone Ampoules (Apr. 16 2019)
Availability of Azithromycin Vial (Apr. 11 2019)
Availability of Local Anaesthetic Products (Mar. 29 2019)
Availability of Somac Granules (Mar. 29 2019)
Packaging Change for Bicillin L-A (Mar. 08 2019)
Availability of Local Anaesthetic Products (Mar. 04 2019)
Availability of Dicloxacillin (Feb. 21 2019)
Product Defect Correction for Jurnista® (Feb. 14 2019)
Availability of Sulfamethoxazole + Trimethoprim (Feb. 04 2019)
Availability of Local Anaesthetic Products (Feb. 01 2019)
Recall for Empovir® Vials (Jan. 30 2019)
Discontinuation of Emend® Capsules (Jan. 24 2019)
Availability of Chlorvescent® Tablets (Jan. 24 2019)
Availability of Citracal Tablets (Jan. 18 2019)
Availability of Pantoprazole Vials (Jan. 11 2019)
Availability of Sinemet CR® (Jan. 02 2019)
Recall for Milrinone (Jan. 02 2019)
